DuP 996 (3,3-bis(4-pyrindinylmethyl)-1-phenylindolin-2-one) enhances the stimulus-induced release of acetylcholine from rat brain in vitro and in vivo
Authors:
- 1 January 1990
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 19 (3) , 285-300
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cognition enhancement by the acetylcholine releaser DuP 996Drug Development Research, 1990
- Clinical Studies of the Cholinergic Deficit in Alzheimer's DiseaseJournal of the American Geriatrics Society, 1985
- Efficacy of oral physostigmine in primary degenerative dementiaPsychopharmacology, 1985
- Oral physostigmine treatment of patients with Alzheimer's diseaseAmerican Journal of Psychiatry, 1985
- Acetylcholinesterase activity in intact and homogenized skeletal muscle of the frog.The Journal of Physiology, 1984
- Oral physostigmine and lecithin improve memory in Alzheimer diseaseAnnals of Neurology, 1983
- Apomorphine and Other Dopaminomimetics: Basic Pharmacology, Vol. IAmerican Journal of Psychiatry, 1982
- Differences in presynaptic ?-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)- and (-)mianserinPsychopharmacology, 1981
- [14C]acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortexBiochemical Journal, 1981
- Preferential release of newly synthesized 3H‐acetylcholine from rat cerebral cortex slices in vitroBritish Journal of Pharmacology, 1973